OXY-KESSO-TETRA Drug Patent Profile
✉ Email this page to a colleague
When do Oxy-kesso-tetra patents expire, and what generic alternatives are available?
Oxy-kesso-tetra is a drug marketed by Ferrante and is included in one NDA.
The generic ingredient in OXY-KESSO-TETRA is oxytetracycline hydrochloride. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXY-KESSO-TETRA?
- What are the global sales for OXY-KESSO-TETRA?
- What is Average Wholesale Price for OXY-KESSO-TETRA?
Summary for OXY-KESSO-TETRA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Patent Applications: | 2,591 |
| DailyMed Link: | OXY-KESSO-TETRA at DailyMed |
US Patents and Regulatory Information for OXY-KESSO-TETRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferrante | OXY-KESSO-TETRA | oxytetracycline hydrochloride | CAPSULE;ORAL | 060179-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
